2025-12-06 - Analysis Report
Okay, let's break down the analysis of Intuitive Surgical (ISRG) based on the provided data.

**1. Return Rate Comparison (ISRG vs. S&P 500)**

*   **Company Overview:** Intuitive Surgical Inc. designs, manufactures, and markets robotic-assisted surgical systems.
*   **ISRG Cumulative Return:** 110.56%
*   **VOO (S&P 500) Cumulative Return:** 100.58%
*   **Divergence:**
    *   Current: 10.9
    *   Relative Divergence: 35.6
*   **Analysis:** ISRG has outperformed the S&P 500 over the analyzed period, with a current cumulative return 10% higher. The relative divergence of 35.6 indicates that while ISRG is currently outperforming VOO, its outperformance is in the lower-middle of its historical range relative to VOO. This suggest the magnitude of outperformance isn't excessive compared to previous periods.

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 68.0% | 77.6% | 40.0% | -0.1 | 43.8 |
| 2016-2018  | 64.0% | 72.2% | 49.0% | -0.0 | 57.5 |
| 2017-2019  | 54.0% | 72.2% | 31.0% | 0.2 | 70.9 |
| 2018-2020  | -6.0% | 80.4% | -29.0% | 0.3 | 98.2 |
| 2019-2021  | 29.0% | 80.4% | -18.0% | 0.6 | 129.3 |
| 2020-2022  | -23.0% | 80.4% | -22.0% | 1.2 | 95.5 |
| 2021-2023  | -17.0% | 77.5% | -18.0% | 1.7 | 121.4 |
| 2022-2024  | 36.0% | 77.5% | 15.0% | 1.7 | 187.9 |
| 2023-2025  | 73.0% | 72.7% | 8.0% | 0.8 | 205.1 |

*   **CAGR:** The Compound Annual Growth Rate is highly variable. The more recent years show strong growth, while some periods show negative growth.
*   **MDD:** Maximum Drawdown consistently high, indicating significant volatility/risk.
*   **Alpha:** Alpha is decreasing overall. More recent periods show negative Alpha, meaning ISRG is underperforming relative to its risk-adjusted expected return.
*   **Beta:** Beta is generally low. Some are even in minus, which is a possible signal of higher performance during recession. More recent periods show a beta increasing, indicating ISRG's price is becoming more sensitive to market movements.
*   **Cap(B):** Market Cap has generally increased over time, showing company growth in size.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** 569.71
*   **Last Market Data:** Price: 571.95, Previous Close: 568.63, Change: 0.58
*   **5-day SMA:** 569.88
*   **20-day SMA:** 563.04
*   **60-day SMA:** 499.22
*   **Analysis:** The stock price is currently fluctuating around its 5-day SMA, a little above its 20-day SMA and well above its 60-day SMA. The price is in an upward trend as all SMAs are rising. The latest close is showing a small uptick and last market data shows a slight price increase and change from previous close.

**3. Technical Indicators & Expected Return**

*   **MRI (Market Risk Indicator):** 0.8 (Medium Investment)
*   **RSI:** 48.67 (Neutral - neither overbought nor oversold)
*   **PPO:** -0.56 (Negative, suggesting slight downward momentum)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (1 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-11-03)
*   **Recent Relative Divergence Change:** -0.9 (Short-term decline)
*   **Expected Return:** 23.1% (Long-term excess return compared to S&P 500)
*   **Analysis:** The MRI suggests a medium investment recommendation. The RSI and PPO are currently providing mixed signals, not strongly indicating a buy or sell opportunity. The hybrid signal indicates a buy recommendation. The recent decline in relative divergence suggests short-term downward pressure. However, the expected return is positive, indicating long-term potential. The fact that recent price change from previous close is small suggests the stock price is not under high fluctuation.

**4. Recent News & Significant Events (Yahoo Finance):**

*   **Positive Sentiment:** Several articles suggest a buying opportunity based on high margins, strong fundamentals, and a revisiting of valuation after a recent rally.
*   **Cautious Commentary:** One article mentions that the stock declined due to management's cautious commentary.
*   **Institutional Holding:** An article highlights a significant position held by Brown Advisory Inc.
*   **Overall Analysis:** The news is mixed, with some analysts and articles suggesting a buy, while others point to potential concerns like management caution. This suggests that a careful analysis is warranted before investing.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출    |
|------------|------|---------|
| 2025-10-22 | 1.98 | 2.51 B$ |
| 2025-07-23 | 1.84 | 2.44 B$ |
| 2025-04-23 | 1.95 | 2.25 B$ |
| 2024-10-18 | 1.59 | 2.04 B$ |
| 2025-10-22 | 1.59 | 2.04 B$ |

*   **Analysis:** Revenue and EPS have generally been increasing over the past year, showing healthy growth in the company's financial performance, but the bottom two rows are duplicated and incorrect.

**6. Financial Information (Revenue/Profitability & Capital/Profitability)**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-09-30   | $2.51B   | 66.36%        |
| 2025-06-30   | $2.44B   | 66.31%        |
| 2025-03-31   | $2.25B   | 64.69%        |
| 2024-12-31   | $2.41B   | 68.04%        |
| 2024-09-30   | $2.04B   | 67.41%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE   |
|--------------|----------|-------|
| 2025-09-30   | $16.93B  | 4.16% |
| 2025-06-30   | $17.85B  | 3.69% |
| 2025-03-31   | $17.11B  | 4.08% |
| 2024-12-31   | $16.43B  | 4.17% |
| 2024-09-30   | $15.58B  | 3.63% |

*   **Analysis:** Revenue and profit margins are both consistently strong, indicating good operational efficiency. Equity has generally increased, with a small dip in the most recent quarter. ROE has been fluctuating, but remains relatively healthy.

**7. Comprehensive Analysis (Summary)**

*   **Performance:** ISRG has outperformed the S&P 500, but recent Alpha has been negative.
*   **Technicals:** The price is in an upward trend but RSI and PPO are not giving strong signals, while hybrid signal recommend a buy.
*   **News:** Recent news is mixed, with some positive and some cautionary articles.
*   **Financials:** Revenue, profit margins, and equity are generally increasing.
*   **Analyst Opinions:** Analyst consensus is a "Buy" with a target price above the current price, implying potential upside.
*   **Overall:** Intuitive Surgical appears to be a fundamentally strong company with positive long-term growth potential. However, recent performance relative to the market has been weaker, and the news flow is mixed. The technical indicators are not strongly bullish or bearish.

**Recommendation:** The data suggests a cautious approach. While ISRG has good financials and long-term potential, the recent underperformance and mixed signals from technical indicators and news warrant careful consideration. A small initial position might be appropriate, with the potential to add more if the stock shows signs of renewed outperformance and positive momentum. It's essential to monitor news and financial results closely.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.